Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Massachusetts for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Massachusetts only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Massachusetts (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Joshua Katz (NPI 1659367522)

Field	Value
Entity Type	Individual
Organization	Joshua Katz
Address	110 Cedar St Ste 110
City	Wellesley
State	MA
ZIP	02481
Taxonomy	Neurology Physician
NPI Enumerated	September 26, 2005

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

Medicare revenue for this provider is highly concentrated: total Medicare revenue is $1.8M and the precomputed top 3 Medicare codes by revenue account for 99.4% of that total. The single code J2350 alone represents $1.8M and 98.2% of the provider's Medicare revenue, indicating an extreme dependence on one product line for payer income. This concentration means fluctuations in reimbursement or utilization for J2350 would materially affect the practice's Medicare revenue.

The provider’s billing mix is consistent with an infusion-centered neurology practice: J2350 (Injection, ocrelizumab) accounts for nearly all Medicare revenue and the presence of infusion and chemotherapy administration codes (96413, 96415, 96367) indicates routine intravenous drug administration. Office evaluation-and-management codes (99214, 99215, 99213) contribute only a trivial share of revenue, suggesting the business model prioritizes drug administration visits over traditional office follow-ups.

Volume metrics for the dominant drug code are substantial: J2350 shows 37.8K claims with a $47 avg paid/claim and $1.8M revenue, and the provider ranks #6 of 105 providers nationally (95th percentile) for that code. The dataset characterizes this as a "typical, unremarkable volume for this code," which suggests the provider is large within a relatively small peer group for J2350 but not flagged as an unusual outlier by the benchmarking labels.

This provider is effectively single-payer in the available data: Medicare revenue is $1.8M and there is no Medicaid billing on file (none). Analysts should treat the practice as relying on Medicare reimbursement flows and not as a mixed Medicare/Medicaid operation when evaluating payer mix risk or contracting strategy.

Competitive standing on ancillary codes is modest: 96413 (chemotherapy administration) has 79 claims, $122 avg paid/claim, $9.6K revenue and ranks #4999 of 7514 providers nationally (33th percentile), while 99214 ranks #215625 of 479517 (55th percentile) and 99215 ranks #68014 of 145531 (52th percentile). Each of these codes is labeled in the data as "typical, unremarkable volume for this code," indicating the provider participates at expected levels for infusion and E/M services outside of the dominant drug code.

There is a notable billing artifact in the record: J1100 appears with 1.6K claims but shows a $0 avg paid/claim and $0 revenue. This pattern is unusual in the sense that many claims were submitted for that code but no Medicare payment is recorded, and it should be investigated further as an operational or claims-submission anomaly rather than assumed to be revenue-generating.

The provider has a long Medicare enrollment history: the NPI was enumerated 2005-09-26 (~21 years ago), which supports a sustained participation in Medicare. Combined with the heavy revenue concentration in J2350, this suggests an established, focused infusion practice that has operated in the Medicare market for multiple years and may have mature clinical and billing workflows tailored to high-volume infusible drug administration.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

8 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	37,810	$50	$1.8M
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	130	$100	$12.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	80	$120	$9.6K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	40	$140	$5.7K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	90	$30	$2.2K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	80	$30	$2.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	10	$50	$710
J1100	Injection, dexamethasone sodium phosphate, 1 mg	1,560	$0	$0

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 8 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Massachusetts Distribution

Joshua Katz — 1 of 7 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Massachusetts

Full comparison — all codes billed, vs. state median

8 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	1	10	33,600	$40	$1.2M
96413	41	60	120	$110	$17.6K
99214	6,924	15,410	110	$80	$15.6K
99215	3,100	6,360	40	$120	$8.9K
99213	13,011	13,700	70	$60	$8.8K
96415	24	50	90	$20	$3.2K
96367	6	20	60	$20	$2K
J1100	20	160	170	$1	$80

Related Providers

Other providers that share a Tax Identification Number (TIN) with Joshua Katz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Andrew Bouley	MA	Neurology Physician	$602.8K	$0

Nearby Providers

Other providers in the same ZIP code as Joshua Katz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Dermpath New England, LLC	MA	Clinical Medical Laboratory	$685.6K	$643K
Boston Endoscopy Center, LLC	MA	Endoscopy Clinic/Center	$1.1M	$0
Daihung Do	MA	MOHS-Micrographic Surgery Physician	$698.1K	$0
Jessica Mosher	MA	MOHS-Micrographic Surgery Physician	$696.1K	$0
Caroline Baumal	MA	Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician	$485K	$0
Omar El Abd	MA	Interventional Pain Medicine Physician	$423K	$0
Steven Smith	MA	MOHS-Micrographic Surgery Physician	$420.1K	$0
Carin Litani	MA	MOHS-Micrographic Surgery Physician	$404.8K	$0
Boston Breast Diagnostic Center LLC	MA	Mammography Clinic/Center	$382.8K	$5.7K
James Phillips	MA	Orthopaedic Surgery Physician	$306.9K	$43.2K

Joshua Katz — Billing Profile & Reimbursement Data

Sign up for Joshua Katz — Billing Profile & Reimbursement Data policy alerts

Joshua Katz — Billing Profile & Reimbursement Data

Sign up for Joshua Katz — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References